Graves' disease complicated by concurrent thyroid eye disease and pretibial myxedema successfully treated with teprotumumab.
Brendan K BowensEva ChouDavid P LaChanceJames R HuynhPatrick VoorheesThanh C DoMohamed K M ShakirThanh Duc HoangPublished in: Clinical case reports (2022)
We report a 51-year-old woman with thyroid eye disease and biopsy-proven pretibial myxedema that was subsequently treated with teprotumumab with improvement.